A , B , C , D , E , F , G , H , I , J , K , L , M , N , O , P , Q , R , S , T , U , V , W , X , Y , Z
| Kürzel | Test | Einh. | Normalbereich | Hinweis | ||
| HGEG | A. phagocytophilum IgG | 0.0 | - | 64.0 | MATERIAL: Serum; Methode: IFT | |
| HGEM | A. phagocytophilum IgM | 0.0 | - | 20.0 | MATERIAL: Serum; Methode: IFT | |
| ATRYP | A1-Antitrypsin | mg/dl | 90.00 | - | 200.00 | MATERIAL: Serum, METHODE: turbidimetrisch |
| ATRYPGEN | A1-Antitrypsin Genotyp | - | MATERIAL: EDTA, Methode: molekulargenetischer Nachweis | |||
| ATRYPST | A1-Antitrypsin i.St. | mg/g St. | 0.000 | - | 0.300 | MATERIAL: Stuhl |
| ATRYPPH | A1-Antitrypsin-Phänotyp | - | MATERIAL: Serum | |||
| A1GLY | A1 saures Glycoprotein | mg/dl | 50.00 | - | 120.00 | MATERIAL: Serum, METHODE: turbidimetrisch |
| ABPATH | Abstrich auf pathogene Keime | - | MATERIAL: Abstrich, METHODE: Kultur | |||
| ACE | ACE (Angiot.Conv.Enzyme) | U/l | 20.0 | - | 70.0 | MATERIAL: Serum, METHODE: photometrisch |
| AC | Aceton i.H. | - | MATERIAL: Spontanharn, METHODE: STIX | |||
| ACRAK | Acetylcholinrezeptor-AK | nmol/l | 0.000 | - | 0.400 | MATERIAL: Serum |
| ACTH | ACTH | pg/ml | 7.200 | - | 63.300 | MATERIAL: EDTA, METHODE: CLIA |
| ADALIMU | Adalimumab | ug/ml | 5.000 | - | 12.000 | MATERIAL: Serum |
| ADALIMUAK | Adalimumab Anti-Drug-Antikörper | ng/ml | 0.00 | - | 10.00 | MATERIAL: Serum |
| ADAMTS13 | ADAMTS13-Aktivität | % | - | MATERIAL: Citrat, METHODE: FRET-Assay | ||
| ADENOPCR | Adenovirus (DNA) PCR | - | MATERIAL: Abstrich,Harn,Stuhl, METHODE: PCR | |||
| ADG | Adenovirus-IgG | U/ml | < | 22.000 | MATERIAL: Serum, METHODE: ELISA | |
| ADM | Adenovirus-IgM | RATIO | < | 1.100 | MATERIAL: Serum, METHODE: ELISA | |
| AD-KBR | Adenovirus KBR | Titer | 0.0 | - | 40.0 | MATERIAL: Serum, METHODE: KBR |
| ADH | ADH/Vasopressin | - | MATERIAL: Serum | |||
| ADHU | ADH/Vasopressin i.H. | pmol/l | 0.93 | - | 104.00 | MATERIAL: Spontanharn |
| ADINEKTIN | Adiponektin | µg/l | - | MATERIAL: Serum | ||
| ADRS | Adrenalin (P) | pg/ml | 30.0 | - | 90.0 | MATERIAL: EDTA Plasma, METHODE: HPLC |
| ADRH | Adrenalin i.24h H. | ug/24h | 4.00 | - | 20.00 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
| AFP | AFP (A-1-Fetoprotein) | ng/ml | 0.00 | - | 15.00 | MATERIAL: Serum, METHODE: CMIA |
| LACTOFAK | AK gegen Lactoferrin | U/ml | 0.0 | - | 9.9 | MATERIAL: Serum, METHODE: EIA |
| ACTABS | Aktivierte T-Zellen absolut | /mm3 | 0.0 | - | 100.0 | MATERIAL: EDTA, METHODE: Flow cytometrie |
| ACTREL | Aktivierte T-Zellen relativ | % | 2.0 | - | 12.0 | MATERIAL: EDTA-Blut, METHODE: Flow cytometrie |
| ALBENDAZOL | Albendazol | ug/ml | - | MATERIAL: Serum, METHODE: HPLC | ||
| ALB | Albumin | % | 55.80 | - | 66.10 | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese |
| ALBU | Albumin | mg/dl | 3500.0 | - | 5500.0 | MATERIAL: Serum, METHODE: photometrisch |
| ALBUH | Albumin i.H. | mg/l | 0.00 | - | 20.00 | MATERIAL: Spontanharn, METHODE: turbidimetrisch |
| ALBUP | Albumin im Punktat | mg/dl | - | MATERIAL: Punktat, METHODE: photometrisch | ||
| ALBKREAQU | Albumin Kreatinin Ratio i.H. | mg/g | 0.00 | - | 30.00 | |
| ALD | Aldolase | U/l | 0.000 | - | 7.600 | MATERIAL: Serum, METHODE: photometrisch |
| ALDRENQL | Aldost.-Renin-Quotient liegend | - | ||||
| ALDOS | Aldosteron | ng/l | 25.600 | - | 445.000 | MATERIAL: Serum, METHODE: CLIA |
| ALDOSH | Aldosteron /g Krea i.H. | ug/g Krea | 1.500 | - | 20.000 | MATERIAL: Spontanharn + Borsäure angesäuerter Harn |
| ALDOSLIEG | Aldosteron im Liegen | ng/l | 19.700 | - | 260.000 | MATERIAL: Serum, METHODE: CLIA |
| ALDRENQ | Aldosteron-Renin-Quotient | - | ||||
| APK | Alk.Phos.Isoenzym Knochen | % | 7.00 | - | 60.00 | MATERIAL: Serum/Vollblut |
| APL | Alk.Phos.Isoenzym Leber | % | 7.00 | - | 60.00 | MATERIAL: Serum/Vollblut |
| AP | Alk.Phosphatase | U/l | 40.0 | - | 150.0 | MATERIAL: Serum, METHODE: photometrisch |
| APISO_RES | Alk.Phosphatase Isoenzyme | - | MATERIAL: Serum/Vollblut, METHODE: IFE | |||
| ALFAA | Alpha 1 | % | 2.90 | - | 4.90 | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese |
| ALFAAA | Alpha 1 | g/dl | 0.210 | - | 0.350 | |
| XA1MGUKR | Alpha-1-Mikroglob. /g Krea i.H. | mg/g Krea. | 0.00 | - | 14.00 | XMATERIAL: Spontanharn, METHODE: Turbitimetrisch |
| A1MGUKR | Alpha-1-Mikroglob. /g Krea i.H. | mg/g Krea. | 0.00 | - | 14.00 | MATERIAL: Spontanharn, METHODE: Turbitimetrisch |
| A1MGU | Alpha-1-Mikroglobulin i.H. | mg/dl | 0.00 | - | 2.00 | MATERIAL: Spontanharn, METHODE: Turbitimetrisch |
| ALFAB | Alpha 2 | % | 7.10 | - | 11.80 | MATERIAL: Serum/Vollblut, METHODE: Elektrophorese |
| ALFABA | Alpha 2 | g/dl | 0.510 | - | 0.850 | |
| A2MG | Alpha-2-Makroglobulin | g/l | 1.300 | - | 3.000 | MATERIAL: Serum, METHODE: turbidimetrisch |
| ALPHAGLA | Alpha-Galaktosidase A i.Leuko | nmol/h/mg | 14.000 | - | 72.600 | MATERIAL: EDTA; METHODE: CMIA |
| ALPRAZOLAM | Alprazolam | ug/l | 5.00 | - | 50.00 | MATERIAL: Serum, METHODE: LC-MS |
| ALUKR | Aluminium /g Krea i.H. | ug/g Krea | 0.00 | - | 60.00 | MATERIAL: Spontanharn, METHODE: AAS/Clia |
| ALH | Aluminium im 24h H. | ug/24h | 0.00 | - | 60.00 | MATERIAL: 24h-Sammelharn, METHODE: AAS |
| AL | Aluminium im Serum | ug/l | 0.00 | - | 10.00 | MATERIAL: Serum, METHODE: AAS |
| AMA | AMA | Titer | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | ||
| AMAM2 | AMA-M2 | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
| AMH | AMH (Anti Müller Hormon) | pmol/l | - | MATERIAL: Serum, METHODE: EIA | ||
| MIKACIN | Amikacin | mg/l | - | MATERIAL: Serum; METHODE: KIMS | ||
| AMINOU | Aminosäuren i.H. | - | MATERIAL: Spontanharn, Methode: | |||
| AMINOS | Aminosäuren im EDTA-Plasma | - | MATERIAL: EDTA-Plasma Methode: Chromatographie | |||
| AMIO | Amiodaron | ug/l | 1000.0 | - | 2500.0 | MATERIAL: Serum, METHODE: HPLC |
| AMISULPRID | Amisulprid | ng/ml | 100.00 | - | 320.00 | MATERIAL: Serum, METHODE: |
| AMITRYPT | Amitriptylin + Nortriptylin | ug/l | 80.00 | - | 200.00 | MATERIAL: Serum, METHODE: LC-MS |
| ENTIHA | Amoeben IHA | - | MATERIAL: Serum/Vollblut, METHODE: indir.Hämagglut. | |||
| AMPS | Amphetamine (S) | µg/l | - | MATERIAL: Serum, METHODE: FPIA | ||
| AMPH | Amphetamine i.H. | ng/ml | 0.0 | - | 1000.0 | MATERIAL: Spontanharn, METHODE: EMIT |
| AMYLS | Amylase gesamt | U/l | 5.0 | - | 160.0 | MATERIAL: Serum, METHODE: photometrisch |
| AMYLH | Amylase i.H. | U/l | 16.0 | - | 491.0 | MATERIAL: Spontanharn, METHODE: photometrisch |
| AMYLMACRO | Amylase Makro | - | MATERIAL: Serum, METHODE: Isoenzymelphor | |||
| AMYLPANK | Amylase Pankreas | U/l | 13.0 | - | 53.0 | MATERIAL: Serum, METHODE: photometrisch |
| AMYLPAROT | Amylase Parotis | U/l | 18.0 | - | 65.0 | MATERIAL: Serum, METHODE: Isoenzymelphor |
| AMYLOIDA | Amyloid A Protein | mg/l | 0.00 | - | 6.30 | MATERIAL: Serum, |
| AMYLOIDß42 | Amyloid ß-42 Protein | mg/l | 0.00 | - | 6.30 | MATERIAL: Serum, |
| ANAMUSTER | ANA Fluoreszenzmuster | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
| AAKIFT | ANA IFT | Titer | < | 160.0 | MATERIAL: Serum, METHODE: Immunfluoreszenz | |
| ANA | ANA Screening | - | MATERIAL: Serum, METHODE: Immunfluoreszenz | |||
| ANCA | ANCA | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
| CANCA | ANCA-c (anti-PR-3) | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum, METHODE: CLIA |
| PANCA | ANCA-p (anti-MPO) | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum/Vollblut, METHODE: CLIA |
| ANDRO | Androstendion | ng/ml | 0.300 | - | 3.700 | MATERIAL: Serum, METHODE: ELISA |
| ANTIB1 | Antibiogramm zu Erreger 1 | - | MATERIAL: Abstrich, METHODE: Kultur | |||
| ANTIB2 | Antibiogramm zu Erreger 2 | - | MATERIAL: Abstrich, METHODE: Kultur | |||
| ANTIB3 | Antibiogramm zu Erreger 3 | - | MATERIAL: Abstrich, METHODE: Kultur | |||
| FXaAKTind | Anti-Fak.Xa-Aktiv. dir/indir | U/ml | - | MATERIAL: Citrat, METHODE: koagulometrisch | ||
| FXaAKTdir | Anti-Fak.Xa-Aktiv. direkt | ng/ml | - | MATERIAL: Citrat, METHODE: koagulometrisch | ||
| AKDIFF | Antikörper-Differenzierung | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
| AKSUCH | Antikörper-Suchtest (ICT) | - | MATERIAL: EDTA, METHODE: Gelzentrifugation | |||
| SBU | Antimon i.H. | ug/l | < | 0.20 | MATERIAL: Spontanharn, METHODE: AAS | |
| SB | Antimon im Serum | ug/l | < | 0.20 | MATERIAL: Serum, METHODE: AAS | |
| MYK | Antimykogramm | - | MATERIAL: Epithelien/Abstrich | |||
| ANTIOX | Antioxidantienstatus | - | Material: Serum+EDTA Methode:diverse | |||
| APS | Anti-phospholipid Syndrom | - | Material: Serum+Citrat Methode: diverse | |||
| PTAK | Anti Prothrombin Ak Scr. | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum/Vollblut METHODE: ELISA |
| ASTA | Antistaphylolysin - Titer | U/ml | 0.00 | - | 2.00 | MATERIAL: Serum, METHODE: Agglutination |
| ADN | Antistrepto DNase B | U/ml | 0.0 | - | 187.0 | MATERIAL: Serum, |
| AST | Antistreptolysin - Titer | U/ml | 0.0 | - | 200.0 | MATERIAL: Serum, METHODE: turbidimetrisch |
| AT3 | Antithrombin III | % | 80.00 | - | 120.00 | MATERIAL: Citrat, METHODE: chromogenes Substrat |
| AP50 | AP50/Altern.Pathway | % | 66.0 | - | 130.0 | MATERIAL: Serum, |
| APC | APC Resistenz | % | 0.00 | - | 10.00 | MATERIAL: Citratplasma; METHODE:chromogenes Substrat |
| APO10 | APO10 | - | MATERIAL: EDTA, METHODE: | |||
| APOQ | ApoB/ApoA1 Quotient | 0.350 | - | 1.250 | ||
| APOE | APO E Polymorphismus (MGen) | - | MATERIAL: EDTA, METHODE: PCR | |||
| APOA | Apolipoprotein A-1 | mg/dl | - | MATERIAL: Serum, METHODE: turbidimetrisch | ||
| APOB | Apolipoprotein B | mg/dl | - | MATERIAL: Serum, METHODE: turbidimetrisch | ||
| APOLIPE | Apolipoprotein E | mg/dl | 2.30 | - | 6.30 | MATERIAL: Serum, METHODE: NEPH |
| AQUAPOR4AK | Aquaporin-4 Antikörper | Titer | - | MATERIAL: Serum, METHODE: IFT | ||
| O6_AA | Arachidonsäure (AA) | mg/l | 172.000 | - | 335.000 | MATERIAL: Serum/Vollblut |
| ARIPIPRA | Aripiprazol | ug/l | 100.0 | - | 350.0 | MATERIAL: Serum, METHODE: LC-MS/MS |
| ASU | Arsen i.H. | ug/l | 0.000 | - | 15.000 | MATERIAL: Spontanharn, METHODE: AAS |
| AS | Arsen im Serum | ug/l | 0.000 | - | 10.000 | MATERIAL: Serum, METHODE: AAS |
| ASV | Arsen im Vollblut (EDTA) | ug/l | 0.000 | - | 10.000 | MATERIAL: EDTA; METHODE: ICP-MS |
| ASCARIS_AK | Ascaris lumbricoides IgG | Units | < | 9.00 | MATERIAL: Serum, METHODE: | |
| ASPERGAG | Aspergillus-AG (Galaktomannan) | - | MATERIAL: Serum, METHODE: ELISA | |||
| ASPERGA | Aspergillus IgA | U/ml | 0.0 | - | 70.0 | MATERIAL: Serum, METHODE: ELISA |
| ASPERGG | Aspergillus IgG | U/ml | 0.0 | - | 70.0 | MATERIAL: Serum, METHODE:ELISA |
| ASTROPCR | Astrovirus (RNA) PCR | - | MATERIAL: Stuhl, METHODE: PCR | |||
| ATOMOXETIN | Atomoxetin | ng/ml | 200.00 | - | 1000.00 | MATERIAL: Serum, METHODE: |
| ATP | ATP intracellulär | umol/l | > | 2.500 | MATERIAL: Heparinblut; Methode: CLIA | |